Leading pharmaceutical organisations pressed for urgent measures to share coronavirus vaccines globally and inoculate the world’s entire adult population by the end of the year.
While advanced countries have made progress with vaccination programmes, shots “are not equally reaching all priority populations worldwide,” eight major drug organisations and associations noted in a joint statement.
They said, “Manufacturers, governments, and non-governmental organizations must work together to take urgent steps to further address this inequity.”
An estimated 11 billion vaccine doses could be produced by the end of 2021, compared with 2.2 billion at the end of May, according to the groups based in Europe and the United States.
To reach their target, the lobby group urged stakeholders to boost vaccine sharing, in particular via the Covax programme that provides them to poorer countries, and to raise production levels.